.png){kind=icon}
C51: Mouse Colon Carcinoma
(actual study data; representative)
| Parameter | Information |
|---|---|
| Strain | Balb/c |
| Implant Type | Fragments |
| Implant Location | SC, Axilla |
| Time to Staging | 12 days |
| Time to 750mm3 | 24.1 days |
| Td | 4.8 days |
(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact Covance.)
***Please note that cell lines are not for sale and unavailable for purchase from Covance.***
Fill out our tumor models contact form to get started setting up your next preclinical study with us.
Histotype:Colon
Tumor Line:Mouse
REF#229
Related Cell Lines:
- NCI-H508
- CT26.WT
- C26
- SW-620
- SW-480
- LS411N
- LS 174T
- LoVo-6-Luc1
- LoVo
- HT-29-Luc
- HT-29
- HCT-8
- HCT-15
- HCT-116-Luc
- HCT-116
- HCC2998
- DLD-1
- COLO 205-Luc #2
- COLO 205
- Caco-2
- C2BBe1
Related Model Spotlights:
- Colo-205 as a translational imaging model for colorectal cancer
- HT-29 as a preclinical model for colorectal cancer
- MC38: An immunoresponsive murine tumor model
- Characterization of proliferation in multiple lymphocyte subsets in the CT26 murine colon carcinoma model by multi-color flow cytometry
- High-throughput analysis of MAPK and JAK-STAT signaling in CT26 tumors using a combination of immunophenotyping and phospho-flow cytometry
- In-depth myeloid cell characterization in the murine syngeneic CT.26 colon carcinoma model by 10-color flow cytometry